36 related articles for article (PubMed ID: 19461082)
1. Key roles of the cytotechnologists and biomedical scientists in interventional pathology: The foundation of a seamless workflow.
Del Mar Olmo Fernandez M; Wheeldon L; Villar-Zarra K
Cytopathology; 2024 Mar; ():. PubMed ID: 38519868
[TBL] [Abstract][Full Text] [Related]
2. Liquid-Based Cervical Cytology: Monitoring the Laboratory Quality Indicators.
Nayak SS; Dutta A; Khedkar R; Roy S
J Cytol; 2024; 41(1):1-7. PubMed ID: 38282808
[TBL] [Abstract][Full Text] [Related]
3. Cervical Cytology and Histology Correlation as an Analytic Quality Assurance Exercise: Experience from an Accredited Cytology Laboratory.
Belekar SV; Kamal M; Warke AS
J Cytol; 2023; 40(4):205-210. PubMed ID: 38058668
[TBL] [Abstract][Full Text] [Related]
4. Continuous quality improvement program and its results of Korean Society for Cytopathology.
Choi YD; Oh HK; Kim SJ; Kim KH; Lee YK; Kim BS; Jang EJ; Choi YJ; Han EK; Kim DH; Choi Y; Jung CK; Kim SN; Min KW; Yoon SJ; Lee HK; Choi KU; Yoon HK
J Pathol Transl Med; 2020 May; 54(3):246-252. PubMed ID: 32460477
[TBL] [Abstract][Full Text] [Related]
5. Current Cytology Practices in Korea: A Nationwide Survey by the Korean Society for Cytopathology.
Oh EJ; Jung CK; Kim DH; Kim HK; Kim WS; Jin SY; Yoon HK;
J Pathol Transl Med; 2017 Nov; 51(6):579-587. PubMed ID: 28950443
[TBL] [Abstract][Full Text] [Related]
6. Is 58% sensitivity for detection of cervical intraepithelial neoplasia 3 and invasive cervical cancer optimal for cervical screening?
Austin RM; Zhao C
Cytojournal; 2014; 11():14. PubMed ID: 24987445
[TBL] [Abstract][Full Text] [Related]
7. Quality and liability issues with the Papanicolaou smear: the role of professional organizations in reform initiatives.
Stanley MW
Arch Pathol Lab Med; 1997 Mar; 121(3):321-6. PubMed ID: 9111127
[TBL] [Abstract][Full Text] [Related]
8. Strategies for reducing Papanicolaou smear screening errors: principles derived from data and experience with quality control.
Krieger PA
Arch Pathol Lab Med; 1997 Mar; 121(3):277-81. PubMed ID: 9111118
[TBL] [Abstract][Full Text] [Related]
9. ASC/SIL ratio for cytotechnologists: A survey of its utility in clinical practice.
Renshaw AA; Auger M; Birdsong G; Cibas ES; Henry M; Hughes JH; Moriarty A; Tench W; Wilbur DC; Elsheikh TM
Diagn Cytopathol; 2010 Mar; 38(3):180-3. PubMed ID: 19760762
[TBL] [Abstract][Full Text] [Related]
10. European Guidelines for Quality Assurance in Cervical Cancer Screening. Europe against cancer programme.
Coleman D; Day N; Douglas G; Farmery E; Lynge E; Philip J; Segnan N
Eur J Cancer; 1993; 29A Suppl 4():S1-38. PubMed ID: 8274301
[No Abstract] [Full Text] [Related]
11. HPV detection rate in discordant Pap tests between cytotechnologists and pathologists.
Chhieng DC; Bakdounes K; Connolly M; Gallaspy S; Roberson J; Eltoum I
Diagn Cytopathol; 2009 May; 37(5):320-3. PubMed ID: 19191288
[TBL] [Abstract][Full Text] [Related]
12. Applicability of the Bethesda System 2001 to a public health setting.
Prandi S; Beccati D; De Aloysio G; Fulgenzi P; Gabrielli M; Ghirardini C; Rivasi F; Saragoni L; de Bianchi PS; Bucchi L
Cancer; 2006 Oct; 108(5):271-6. PubMed ID: 16948127
[TBL] [Abstract][Full Text] [Related]
13. Rapid prescreening of Papanicolaou smears: a practical and efficient quality control strategy.
Djemli A; Khetani K; Auger M
Cancer; 2006 Feb; 108(1):21-6. PubMed ID: 16302251
[TBL] [Abstract][Full Text] [Related]
14. ASC/SIL Ratio for Cytotechnologists: A surrogate marker of screening sensitivity.
Renshaw AA; Deschênes M; Auger M
Am J Clin Pathol; 2009 Jun; 131(6):776-81. PubMed ID: 19461082
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
